Legal Representation
Attorney
Christopher N. Bolinger
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 19, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 19, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Aug 22, 2007 | EX5G | S | SOU EXTENSION 5 GRANTED |
| May 16, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 16, 2007 | EXT5 | S | SOU EXTENSION 5 FILED |
| Nov 2, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 2, 2006 | EXT4 | S | SOU EXTENSION 4 FILED |
| Nov 2, 2006 | EX4G | S | SOU EXTENSION 4 GRANTED |
| May 20, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED |
| May 9, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 9, 2006 | EXT3 | S | SOU EXTENSION 3 FILED |
| Feb 14, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 4, 2006 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Nov 4, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 4, 2005 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 3, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 3, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| May 6, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 6, 2005 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 6, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 16, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 24, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 4, 2004 | NPUB | O | NOTICE OF PUBLICATION |
| Jun 28, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 25, 2004 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 23, 2003 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, sleep disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005